In Search for a Convenient, Scalable Synthesis of 5-(3,4-Dihydroxyphenyl)-γ-valerolactone (DHPV): a Closer Inspection of a Condensation/Elimination/Hydrogenation Route

Marta Splandesci; Karyna Kin; Michał Nowacki; Martyna Wróbel; Joanna Giebułtowicz; Sebastian Granica; Joanna Kolmas; Jakub Piwowarski; Maciej Dawidowski

doi:10.56782/pps.1052

Published : 2026-09-24

Vol. 24 No. 3 (2026)

In Search for a Convenient, Scalable Synthesis of 5-(3,4-Dihydroxyphenyl)-γ-valerolactone (DHPV): a Closer Inspection of a Condensation/Elimination/Hydrogenation Route

Marta Splandesci

Karyna Kin

Michał Nowacki

Martyna Wróbel

Joanna Giebułtowicz

Sebastian Granica

Joanna Kolmas

Jakub Piwowarski

Maciej Dawidowski

DOI: https://doi.org/10.56782/pps.1052

Abstract

5-(3,4-Dihydroxyphenyl)-γ-valerolactone (DHPV) is a natural product, which is produced in the human gut by a microbial metabolism of (epi)catechins. Despite this postbiotic metabolite is known for its significant pharmacological potential, there are no reports on its convenient synthesis in multigram quantities. With an aim of finding a convenient source of DHPV for preclinical studies, we have undertaken an effort to verify the potential of a literature method based on a condensation/elimination/hydrogenation sequence. We have reproduced the protocol for both reaction steps and identified bottlenecks that may be addressed to further improve the proposed pathway. These findings constitute a solid background for finding a suitable way to obtain DHPV for its further pharmacological evaluation.

Keywords:

5-(3,4-dihydroxyphenyl)-γ-valerolactone synthesis, DHPV synthesis, postbiotic metabolites, proanthocyanidine metabolites, (epi)catechin metabolites

Most read articles by the same author(s)

Natalia Melnyk, Aleksandra Nyczka, Jakub P. Piwowarski, Sebastian Granica, Traditional Use of Chamomile Flowers (Matricariae flos) in Inflammatory-Associated Skin Disorders , Prospects in Pharmaceutical Sciences: Vol. 22 No. 4 (2024)
Diana Dolzhko, Natalia Melnyk, Aleksandra Kruk, Sebastian Granica, Jakub Piwowarski, Traditional use of polar extracts from lavender flowers – systematic review of literature data , Prospects in Pharmaceutical Sciences: Vol. 22 No. 3 (2024)
Michalina Skóra, Michał Nowacki, Maciej Dawidowski, Sulfoximine derivatives — their pharmacochemical properties, synthesis, and potential in drug discovery , Prospects in Pharmaceutical Sciences: Vol. 24 No. 2 (2026)
Natalia Melnyk, Weronika Skowrońska, Dominik Popowski, Jakub Piwowarski, Sebastian Granica, From Tradition to Mechanism: Anti-inflammatory and Microbiota-Modulating Effects of Calendula officinalis and Matricaria recutita Extracts on the Skin , Prospects in Pharmaceutical Sciences: Early Access (ONLINE FIRST)
Seun Funmilola Akomolafe, Marcin Równicki, Weronika Skowrońska, Sebastian Granica, Comparative in vitro anti-inflammatory, wound-healing, enzyme-inhibitory, and antimicrobial activities of Boswellia dalzielii leaf and stem bark aqueous extracts , Prospects in Pharmaceutical Sciences: Vol. 24 No. 3 (2026)
Julian Chrzanowski, Wojciech Graboń, Sebastian Granica, Miłosz Ludwinek, Aleksandra Zdanowicz, Beata Pyrzyńska, Marta Struga, Agnieszka Cudnoch-Jędrzejewska, Branched-chain amino acids differentially affect proliferation, glucose-lactate metabolism and BCKDHA expression in human lung and pancreatic cancer cells , Prospects in Pharmaceutical Sciences: Vol. 24 No. 3 (2026)

Similar Articles

Bartłomiej Pyrak, Karolina Rogacka, Dariusz Maciej Pisklak, Anti-leukotriene drugs in the therapy of inflammatory diseases , Prospects in Pharmaceutical Sciences: Vol. 20 No. 2 (2022)
Anna Zgadzaj, PHOTOGENOTOXICITY IN IN VITRO STUDIES AND IN BACTERIAL TESTS IN THE YEARS 2013-2018 COMPARED WITH EARLIER PUBLICATIONS IN LIGHT OF CHANGES IN LEGAL REGULATIONS , Prospects in Pharmaceutical Sciences: Vol. 16 No. 3 (2018)
Paweł Żero, Maria Niemyjska, Magdalena Rasztawicka, Dorota Maciejewska, BREAST CANCER DISEASE AND NEW COMPOUNDS WITH ANTICANCER ACTIVITY , Prospects in Pharmaceutical Sciences: Vol. 3 No. 2 (2005)
Magdalena Bielińska, Grzegorz Nałęcz-Jawecki, PHARMACEUTICALS IN THE ENVIRONMENT. I: EVALUATION OF TOXICITY OF THREE FLUOROQUINOLONES TO DUCKWEED LEMNA MINOR , Prospects in Pharmaceutical Sciences: Vol. 7 No. 4 (2009)
Monika Pawłowska, DESIGN AND PROPERTIES ANALYSIS OF MOLECULARLY IMPRINTED POLYMERS. MOLECULAR MODELING METHOD APPLICATION , Prospects in Pharmaceutical Sciences: Vol. 10 No. 2 (2012)
Izabela Łuczak-Zielkiewicz, Mirosław M. Szutowski, DIAGNOSTIC VALUE OF HAIR ANALYSIS , Prospects in Pharmaceutical Sciences: Vol. 11 No. 8 (2013)
Elżbieta Gniazdowska, Edyta Gilant, Katarzyna Buś-Kwaśnik, ICH M10 guideline - a harmonized global approach to bioanalysis , Prospects in Pharmaceutical Sciences: Vol. 21 No. 3 (2023)
Ewa Napiórkowska, Thiamine: overview of history of discovery, mechanism of action, role and deficiency , Prospects in Pharmaceutical Sciences: Vol. 21 No. 3 (2023)
Arzu Birinci Yildirim, Ayca Cimen, Yavuz Baba, Arzu Turker, Natural- and in vitro-grown Filipendula ulmaria (L.) Maxim: evaluation of pharmaceutical potential (antibacterial, antioxidant and toxicity) and phenolic profiles , Prospects in Pharmaceutical Sciences: Vol. 22 No. 1 (2024)
Oliwia Szambora, Katarzyna Paradowska, Problems and challenges in the detection of essential oil adulteration – a review of current analytical methods , Prospects in Pharmaceutical Sciences: Vol. 24 No. 3 (2026)

<< < 1 2 3

You may also start an advanced similarity search for this article.

Details

References

Statistics

Authors

Download files

PDF

Citation rules

Splandesci, M., Kin, K., Nowacki, M., Wróbel, M., Giebułtowicz, J., Granica, S., … Dawidowski, M. (2026). In Search for a Convenient, Scalable Synthesis of 5-(3,4-Dihydroxyphenyl)-γ-valerolactone (DHPV): a Closer Inspection of a Condensation/Elimination/Hydrogenation Route. Prospects in Pharmaceutical Sciences, 24(3), 86–93. https://doi.org/10.56782/pps.1052

Altmetric indicators

Cited by / Share

Licence

This work is licensed under a Creative Commons Attribution 4.0 International License.

References

1. Kutschera, M.; Engst, W.; Blaut, M.; Braune, A. Isolation of catechin-converting human intestinal bacteria. J. Appl. Microbiol. 2011, 111(1), 165–175. DOI: 10.1111/j.1365-2672.2011.05025.x

2. Saura-Calixto, F.; Pérez-Jiménez, J.; Touriño, S.; Serrano, J.; Fuguet, E.; Torres, J. L.; Goñi, I. Proanthocyanidin metabolites associated with dietary fibre from in vitro colonic fermentation and proanthocyanidin metabolites in human plasma. Mol. Nutr. Food Res. 2010, 54(7), 939–946. DOI: 10.1002/mnfr.200900276

3. Manach, C.; Williamson, G.; Morand, C.; Scalbert, A.; Rémésy, C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am. J. Clin. Nutr. 2005, 81(1 Suppl), 230S–242S. DOI: 10.1093/ajcn/81.1.230S

4. Mena, P.; Bresciani, L.; Brindani, N.; Ludwig, I. A.; Pereira-Caro, G.; Angelino, D.; Llorach, R.; Calani, L.; Brighenti, F.; Clifford, M. N.; Gill, C. I. R.; Crozier, A.; Curti, C.; Del Rio, D. Phenyl-γ-valerolactones and phenylvaleric acids, the main colonic metabolites of flavan-3-ols: synthesis, analysis, bioavailability, and bioactivity. Nat. Prod. Rep. 2019, 36(5), 714–752. DOI: 10.1039/C8NP00062J

5. Lee, C. C.; Kim, J. H.; Kim, J. S.; Oh, Y. S.; Han, S. M.; Park, J. H. Y.; Lee, K. W.; Lee, C. Y. 5-(3′,4′-Dihydroxyphenyl)-γ-valerolactone, a major microbial metabolite of proanthocyanidin, attenuates THP-1 monocyte-endothelial adhesion. Int. J. Mol. Sci. 2017, 18(7), Art. No: 1363. DOI: 10.3390/ijms18071363

6. Theodoratou, E.; Kyle, J.; Farrington, S. M.; Barnetson, R.; Tenesa, A.; Cetnarskyj, R.; Dunlop, M.; Porteous, M.; Campbell, H. Dietary flavonoids and the risk of colorectal cancer. Cancer Epidemiol. Biomarkers Prev. 2007, 16(4), 684–693. DOI: 10.1158/1055-9965.EPI-06-0785

7. Yanez-Gascon, M. J.; Larrosa, M.; Simona, T.; Espin, J. C.; Tomas-Barberan, F.; Piero, D.; Selma, M. V.; Gonzalez-Sarrias, A.; Azorin-Ortuno, M. Anti-inflammatory activity of pomegranate extract and urolithin-A in experimental rat colitis and the influence of colonic inflammation on phenolic biotransformation. J. Nutr. Biochem. 2010, 21(8), 717–725. DOI: 10.1016/j.jnutbio.2009.04.012

8. Rechner, A. R.; Kroner, C. Anthocyanins and colonic metabolites of dietary polyphenols inhibit platelet function. Thromb. Res. 2005, 116(4), 327–334. DOI: 10.1016/j.thromres.2005.01.002

9. Kim, T.D.A.; Kim, R.A.; Suh, G.Y.; Sim, H.J. DHPV Novel method for synthesizing DHPV. KR Patent KR102003033B1 2019. https://worldwide.espacenet.com/patent/search/family/067439865/publication/KR102003033B1?q=pn=KR102003033

10. Hur, J.; Kim, A.-R.; Kim, S. H.; Lim, C.; Kim, T.; Kim, T.-A.; Sim, J.; Suh, Y.-G. Concise synthesis of catechin metabolites 5-(3′,4′-dihydroxyphenyl)-γ-valerolactones (DHPV) in optically pure form and their stereochemical effects on skin wrinkle-reducing activities. Molecules 2020, 25(8), Art. No: 1970. DOI: 10.3390/molecules25081970

11. Lambert, J. D.; Rice, J. E.; Hong, J.; Hou, Z.; Yang, C. S. Synthesis and biological activity of the tea catechin metabolites, M4 and M6 and their methoxy-derivatives. Bioorg. Med. Chem. Lett. 2005, 15(4), 873–876. DOI: 10.1016/j.bmcl.2004.12.070

12. Chang, X.; Peng, W.; Yao, Y.-F.; Koek, J. Concise synthesis of ring-fission metabolites of epicatechin: 5-(3,4-dihydroxybenzyl)dihydrofuran-2(3H)-one M6. Synth. Commun. 2010, 40(22), 3346–3352. DOI: 10.1080/00397910903419845

13. Nishirawa, T.; Kubo, H.; Saito, M.; Yoshiue, S.; Tamura, Z. Presence of (±)-δ-(3,4-dihydroxyphenyl)-γ-valerolactone in human urine. Chem. Pharm. Bull. 1974, 22(11), 2573–2577. DOI: 10.1248/cpb.22.2573

Marta Splandesci

marta.splandesci@wum.edu.pl

Affiliation:

a:1:{s:5:"en_US";s:92:"Department of Drug Technology and Pharmaceutical Biotechnology, Medical University of Warsaw";} Poland